CytomX Therapeutics - Stock Price History | CTMX

Historical daily share price chart and data for CytomX Therapeutics since 2021 adjusted for splits. The latest closing stock price for CytomX Therapeutics as of September 27, 2021 is 5.41.
  • The all-time high CytomX Therapeutics stock closing price was 34.22 on March 12, 2018.
  • The CytomX Therapeutics 52-week high stock price is 10.05, which is 85.8% above the current share price.
  • The CytomX Therapeutics 52-week low stock price is 4.28, which is 20.9% below the current share price.
  • The average CytomX Therapeutics stock price for the last 52 weeks is 7.06.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CytomX Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 7.7040 8.5950 14.6400 3.6100 6.5500 -21.18%
2019 10.4178 15.6200 19.1600 5.1700 8.3100 -44.97%
2018 22.8922 21.7600 34.2200 12.6900 15.1000 -28.47%
2017 16.1550 10.7100 23.0900 10.7100 21.1100 92.08%
2016 12.3599 20.4600 20.4600 9.2500 10.9900 -47.34%
2015 15.8232 12.9000 23.6600 9.3000 20.8700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.353B $0.100B
CytomX Therapeutics, Inc. is an oncology focused biopharmaceutical company. The Company is engaged in developing Probody(TM) therapeutics for the treatment of cancer. Its pipeline focuses areas consist of Precision cancer immunotherapy and Probody drug conjugates. CytomX Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29